Please cite:
Dimitra Karagkouni, Maria D. Paraskevopoulou, Serafeim Chatzopoulos, Ioannis S. Vlachos, Spyros Tastsoglou, Ilias Kanellos, Dimitris Papadimitriou, Ioannis Kavakiotis, Sofia Maniou, Giorgos Skoufos, Thanasis Vergoulis, Theodore Dalamagas, Artemis G. Hatzigeorgiou; DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA–gene interactions, Nucleic Acids Research, gkx1141, https://doi.org/10.1093/nar/gkx1141
Bulk download:
We have updated the bulk download module, which simplifies the download process! Please find the new online form by following this link

hsa-miR-99b-5p


Loading... Please wait, this might take a few seconds...



Filters
Clear all
Interactions: 565, Experiments: (low: , high: , unknown: ) Cell lines: , Tissues: , Publications:
Gene name miRNA name Experiments
throughput
Publications Cell lines Tissues Pred. Score
MRPS18C hsa-miR-99b-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Hafner M. et al. 2010 IP Kidney HEK293 N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN PAR-CLIP POSITIVE DIRECT TarBase 6.0
C4orf36 hsa-miR-99b-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Pillai MM et al. 2014 IP Mammary Gland BT474 N/A N/A
Location Method Result Regulation Validation Type Source
chr4:86926267-86926281 HITS-CLIP POSITIVE DIRECT TarBase 7.0
NIPBL hsa-miR-99b-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Pillai MM et al. 2014 IP Mammary Gland BT474 N/A N/A
Location Method Result Regulation Validation Type Source
chr5:36876942-36876968 HITS-CLIP POSITIVE DIRECT TarBase 7.0
UBTD1 hsa-miR-99b-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr10:97571028-97571049 PAR-CLIP POSITIVE DIRECT TarBase 7.0
TTC7B hsa-miR-99b-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Kameswaran V et al. 2014 IP Pancreas BETA Cells N/A N/A
Location Method Result Regulation Validation Type Source
chr14:90780814-90780834 HITS-CLIP POSITIVE DIRECT TarBase 7.0
TRMT61A hsa-miR-99b-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr14:103532616-103532637 PAR-CLIP POSITIVE DIRECT TarBase 7.0
RPL27A hsa-miR-99b-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr11:8684812-8684838 PAR-CLIP POSITIVE DIRECT TarBase 7.0
BLCAP hsa-miR-99b-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Pillai MM et al. 2014 IP Mammary Gland MDAMB231 N/A N/A
Location Method Result Regulation Validation Type Source
chr20:37518809-37518831 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ENGASE hsa-miR-99b-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr17:79085252-79085274 HITS-CLIP POSITIVE DIRECT TarBase 7.0
TUBA1C hsa-miR-99b-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr12:49269618-49269633 PAR-CLIP POSITIVE DIRECT TarBase 7.0
SLC20A2 hsa-miR-99b-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Hafner M. et al. 2010 IP Kidney HEK293 N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN PAR-CLIP POSITIVE DIRECT TarBase 6.0
SEMA4C hsa-miR-99b-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr2:96864325-96864347 HITS-CLIP POSITIVE DIRECT TarBase 7.0
PCSK9 hsa-miR-99b-5p low: 0 high: 1 1 1 1 0.567
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr1:55064472-55064496 PAR-CLIP POSITIVE DIRECT TarBase 7.0
CNBP hsa-miR-99b-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Pillai MM et al. 2014 IP Mammary Gland MDAMB231 N/A N/A
Location Method Result Regulation Validation Type Source
chr3:129171691-129171717 HITS-CLIP POSITIVE DIRECT TarBase 7.0
SIK2 hsa-miR-99b-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A N/A
Location Method Result Regulation Validation Type Source
chr11:111724085-111724112 PAR-CLIP POSITIVE DIRECT TarBase 7.0
KBTBD2 hsa-miR-99b-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Eva Gottwein et al. 2011 IP Pleura BC1 N/A N/A
Location Method Result Regulation Validation Type Source
chr7:32875052-32875073 PAR-CLIP POSITIVE DIRECT TarBase 7.0
ZNF217 hsa-miR-99b-5p low: 0 high: 1 1 1 1 0.486
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Balakrishnan I et al. 2014 IP Bone Marrow HS5 N/A N/A
Location Method Result Regulation Validation Type Source
chr20:53582354-53582363 HITS-CLIP POSITIVE DIRECT TarBase 7.0
CEBPB hsa-miR-99b-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr20:50191402-50191414 PAR-CLIP POSITIVE DIRECT TarBase 7.0
KDM2A hsa-miR-99b-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr11:67255192-67255202 PAR-CLIP POSITIVE DIRECT TarBase 7.0
MGA hsa-miR-99b-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr15:41770614-41770641 HITS-CLIP POSITIVE DIRECT TarBase 7.0